MOZOBIL

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug MOZOBIL contains one active pharmaceutical ingredient (API):

1 Plerixafor UNII S915P5499N - PLERIXAFOR

Plerixafor induces leukocytosis and elevations in circulating haematopoietic progenitor cell levels due to a disruption of CXCR4 binding to its cognate ligand, known as CXCL12, resulting in the appearance of both mature and pluripotent cells in the systemic circulation. CD34+ cells mobilised by plerixafor are functional and capable of engraftment with long-term repopulating capacity. Read about Plerixafor

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MOZOBIL Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L03AX16	Plerixafor	L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AX Other immunostimulants
Discover more medicines within L03AX16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10083Q, 10084R
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 502818120078617, 576720020056417
Country: CA	Health Products and Food Branch	Identifier(s): 02377225
Country: EE	Ravimiamet	Identifier(s): 1433900
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 09537001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 048505
Country: FR	Base de données publique des médicaments	Identifier(s): 60148167
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 161854
Country: HK	Department of Health Drug Office	Identifier(s): 60176
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6406
Country: IT	Agenzia del Farmaco	Identifier(s): 039587011
Country: JP	医薬品医療機器総合機構	Identifier(s): 3399413A1021
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1050715
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 131156
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 16976
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W54580001
Country: SG	Health Sciences Authority	Identifier(s): 13894P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699809779174
Country: US	FDA, National Drug Code	Identifier(s): 0024-5862
Country: ZA	Health Products Regulatory Authority	Identifier(s): 44/32.2/0546